1. Telomeropathies: Etiology, diagnosis, treatment and follow‐up. Ethical and legal considerations
   Romina G. Armando et al, 2019, Clinical Genetics CrossRef
2. Contribution of Syncytins and Other Endogenous Retroviral Envelopes to Human Placenta Pathologies
   P.-A. Bolze et al, 2017, Molecular Biology of Placental Development and Disease CrossRef
3. New drugs are not enough‑drug repositioning in oncology: An update
   Romina Armando et al, 2020, International Journal of Oncology CrossRef
4. Liriopesides B inhibited cell growth and decreased CA125 level in human ovarian cancer A2780 cells
   Haiyan Wang et al, 2017, Natural Product Research CrossRef
5. Rho GTPases as therapeutic targets in cancer (Review)
   G.A. Cardama et al, 2017, International Journal of Oncology CrossRef
6. Revitalizing the AZT Through of the Selenium: An Approach in Human Triple Negative Breast Cancer Cell Line
   Mônica Silveira Wagner et al, 2018, Frontiers in Oncology CrossRef
7. Structural Features of Nucleoprotein CST/Shelterin Complex Involved in the Telomere Maintenance and Its Association with Disease Mutations
   Mohd. Amir et al, 2020, Cells CrossRef
8. Cellular senescence: Silent operator and therapeutic target in cancer
   Deepika Ramu et al, 2021, IUBMB Life CrossRef
9. Melanoma antigens and related immunological markers
   Jacob Pitcovski et al, 2017, Critical Reviews in Oncology/Hematology CrossRef
10. Amphipathic Small Molecule AZT Compound Displays Potent Inhibitory Effects in Cancer Cell Proliferation
    Pethaiah Gunasekaran et al, 2021, Pharmaceutics CrossRef
11. New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis
    Ana F. Castillo et al, 2021, Cellular and Molecular Life Sciences CrossRef